The risks some investors take never cease to amaze me. They will invest in highly speculative unprofitable companies that consistently generate negative Free Cash Flow (FCF) but will overlook Intuitive Surgical (ISRG) with its impeccable Balance Sheet. Just because ISRG is a high-quality company, however, does not mean investors should overlook valuation! I last reviewed [...]
I last reviewed Genuine Parts (GPC) in this July 21 post at which time it had released Q2 and YTD2023 financial results and FY2023 guidance. Now, GPC has released Q3 and YTD 2023 results and its share price has tumbled prompting me to revisit this existing holding. Business Overview Part 1 Item 1 in GPC's [...]
Nasdaq (NDAQ) is targeting higher annual recurring revenue from high-growth areas of business to reduce earnings volatility. I last reviewed Nasdaq (NDAQ) in my September 14 guest post at Dividend Power. At the time of that post, the most currently available financial information was for Q2 2023. On October 18, NDAQ released its Q3 and [...]
I reviewed Q2 and YTD2023 results in this July 19 post. I now quickly revisit Lockheed Martin (LMT) given: the release of its Q3 and YTD2023 results; revised FY2023 outlook; the declaration of a dividend increase; and an increase in its share repurchase authorization. Business Overview Investors unfamiliar with LMT should review its website, Part [...]
In my March 9, 2023 post, I disclosed a new position in BlackRock, Inc. (BLK) in a 'Core' account in the FFJ Portfolio with the purchase of 60 shares @ ~$664. I subsequently acquired: 40 shares on April 26 @ ~$656; and 30 shares @ ~$635 on May 9 (refer to my May 12 post) [...]
In my October 5 guest post at Dividend Power, I present my thoughts on why you should consider Intercontinental Exchange (ICE) as a potential investment given its record of consistent growth and value creation. Some investors make investment decisions based solely on share price behaviour. Share price behaviour, however, does not necessarily always reflect a [...]
This FFJ Portfolio - September 2023 report is an overview of my recent investment activity. Relative to September 2022, the value of the FFJ Portfolio has fallen by ~$1,050 CDN and increased by ~$1,379,063 USD. Purchases In September, I purchased the following: Lockheed Martin (LMT) In my September 7 post, I disclosed the purchase of [...]
Some investors who acquired Nike (NKE) shares in 2021 when they were overvalued, wouldn't consider buying shares now that they are undervalued. Other investors who fixate on stock charts will look at NKE's mid-September 2019 share price and the current share price (~$90 as I compose this post) only to find they are fairly similar [...]
I last reviewed Paychex (PAYX) in this June 30 post at which time I determined shares were attractively valued. This was encouraging considering that for the past several months I struggled to identify fairly or attractively valued high-quality companies. Fortunately, the valuation pendulum has swung significantly of late thus presenting investors with a larger pool [...]
I last reviewed Copart (CPRT) in this September 10, 2022 post at which time I disclosed the purchase of an additional 100 shares in the FFJ Portfolio. Following that purchase, my total CPRT exposure consisted of 450 shares. On November 4, 2022, CPRT initiated a 2-for-1 stock split thereby doubling my holdings to 900; the [...]